Specialty Retail
Build Your Comparison
Side-by-side financial analysisStock Comparison
HEPS vs CPNG vs AMZN vs MELI vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Retail
Specialty Retail
Specialty Retail
Banks - Diversified
HEPS vs CPNG vs AMZN vs MELI vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Retail | Specialty Retail | Specialty Retail | Specialty Retail | Banks - Diversified |
| Market Cap | $888M | $30.19B | $2.57T | $80.59B | $896.00B |
| Revenue (TTM) | $79.46B | $28.65B | $742.78B | $31.80B | $280.33B |
| Net Income (TTM) | $-5.53B | $-165M | $90.80B | $1.92B | $57.05B |
| Gross Margin | 31.9% | 12.7% | 50.6% | 43.9% | 60.0% |
| Operating Margin | -2.4% | 0.3% | 11.5% | 9.6% | 25.9% |
| Forward P/E | — | 152.9x | 27.1x | 40.2x | 14.4x |
| Total Debt | $3.20B | $4.63B | $152.99B | $11.39B | $942.38B |
| Cash & Equiv. | $11.51B | $6.32B | $86.81B | $3.67B | $343.34B |
HEPS vs CPNG vs AMZN vs MELI vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | Jun 26 | Return |
|---|---|---|---|
| D-Market Elektronik… (HEPS) | 100 | 21.3 | -78.7% |
| Coupang, Inc. (CPNG) | 100 | 46.3 | -53.7% |
| Amazon.com, Inc. (AMZN) | 100 | 143.4 | +43.4% |
| MercadoLibre, Inc. (MELI) | 100 | 101.3 | +1.3% |
| JPMorgan Chase & Co. (JPM) | 100 | 211.3 | +111.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HEPS vs CPNG vs AMZN vs MELI vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HEPS is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.90, current ratio 0.89x
- 61.0% revenue growth vs JPM's 3.3%
- Beta 0.90 vs CPNG's 1.52
CPNG lags the leaders in this set but could rank higher in a more targeted comparison.
AMZN ranks third and is worth considering specifically for efficiency.
- 11.5% ROA vs HEPS's -17.7%
MELI is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 39.1%, EPS growth 4.5%, 3Y rev CAGR 38.9%
- 10.9% 10Y total return vs AMZN's 5.7%
- Beta 1.22, current ratio 1.17x
JPM carries the broadest edge in this set and is the clearest fit for income & stability and valuation efficiency.
- Dividend streak 15 yrs, beta 0.94, yield 1.9%
- PEG 0.81 vs AMZN's 0.97
- Lower P/E (14.4x vs 27.1x), PEG 0.81 vs 0.97
- 20.4% margin vs HEPS's -7.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 61.0% revenue growth vs JPM's 3.3% | |
| Value | Lower P/E (14.4x vs 27.1x), PEG 0.81 vs 0.97 | |
| Quality / Margins | 20.4% margin vs HEPS's -7.0% | |
| Stability / Safety | Beta 0.90 vs CPNG's 1.52 | |
| Dividends | 1.9% yield; 15-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +21.8% vs CPNG's -40.6% | |
| Efficiency (ROA) | 11.5% ROA vs HEPS's -17.7% |
HEPS vs CPNG vs AMZN vs MELI vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HEPS vs CPNG vs AMZN vs MELI vs JPM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 4 of 6 categories
AMZN leads 1 • HEPS leads 0 • CPNG leads 0 • MELI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMZN is the larger business by revenue, generating $742.8B annually — 25.9x CPNG's $28.7B. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to HEPS's -7.0%. On growth, MELI holds the edge at +49.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $79.5B | $28.7B | $742.8B | $31.8B | $280.3B |
| EBITDAEarnings before interest/tax | $1.2B | -$45M | $155.9B | $3.9B | $81.4B |
| Net IncomeAfter-tax profit | -$5.5B | -$165M | $90.8B | $1.9B | $57.0B |
| Free Cash FlowCash after capex | $4.1B | $279M | -$2.5B | $10.7B | $100.9B |
| Gross MarginGross profit ÷ Revenue | +31.9% | +12.7% | +50.6% | +43.9% | +60.0% |
| Operating MarginEBIT ÷ Revenue | -2.4% | +0.3% | +11.5% | +9.6% | +25.9% |
| Net MarginNet income ÷ Revenue | -7.0% | -0.6% | +12.2% | +6.0% | +20.4% |
| FCF MarginFCF ÷ Revenue | +5.1% | +1.0% | -0.3% | +33.7% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +39.0% | -74.4% | +16.6% | +49.0% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -3.8% | -3.5% | +74.8% | -15.5% | +16.0% |
Valuation Metrics
JPM leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 16.0x trailing earnings, JPM trades at a 90% valuation discount to CPNG's 152.9x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs AMZN's 1.19x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $888M | $30.2B | $2.57T | $80.6B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $709M | $28.5B | $2.63T | $88.3B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | -6.70x | 152.91x | 33.27x | 40.36x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 27.13x | 40.22x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.19x | — | 0.90x |
| EV / EBITDAEnterprise value multiple | 26.47x | 41.74x | 18.06x | 23.41x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 0.45x | 0.87x | 3.58x | 2.79x | 3.20x |
| Price / BookPrice ÷ Book value/share | 20.40x | 6.75x | 6.28x | 11.94x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 18.79x | 57.84x | 333.39x | 7.48x | 8.88x |
Profitability & Efficiency
AMZN leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
MELI delivers a 29.6% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $-2 for HEPS. AMZN carries lower financial leverage with a 0.37x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), AMZN scores 6/9 vs HEPS's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.4% | -3.7% | +23.3% | +29.6% | +15.9% |
| ROA (TTM)Return on assets | -17.7% | -0.9% | +11.5% | +4.8% | +1.3% |
| ROICReturn on invested capital | — | +14.5% | +14.7% | +20.8% | +4.5% |
| ROCEReturn on capital employed | -54.3% | +5.9% | +15.3% | +28.3% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 6 | 5 | 5 |
| Debt / EquityFinancial leverage | 1.59x | 1.00x | 0.37x | 1.69x | 2.60x |
| Net DebtTotal debt minus cash | -$8.3B | -$1.7B | $66.2B | $7.7B | $599.0B |
| Cash & Equiv.Liquid assets | $11.5B | $6.3B | $86.8B | $3.7B | $343.3B |
| Total DebtShort + long-term debt | $3.2B | $4.6B | $153.0B | $11.4B | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.33x | 8.88x | 39.96x | 14.14x | 0.74x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $2,085 for HEPS. Over the past 12 months, JPM leads with a +21.8% total return vs CPNG's -40.6%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs CPNG's 0.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +9.4% | -28.0% | +5.3% | -19.5% | -0.5% |
| 1-Year ReturnPast 12 months | -1.1% | -40.6% | +11.9% | -32.9% | +21.8% |
| 3-Year ReturnCumulative with dividends | +133.3% | +1.7% | +88.5% | +28.4% | +138.2% |
| 5-Year ReturnCumulative with dividends | -79.2% | -56.3% | +41.0% | +11.0% | +118.2% |
| 10-Year ReturnCumulative with dividends | -79.2% | -65.8% | +567.1% | +1092.7% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +32.6% | +0.6% | +23.5% | +8.7% | +33.6% |
Risk & Volatility
Evenly matched — HEPS and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
HEPS is the less volatile stock with a 0.90 beta — it tends to amplify market swings less than CPNG's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 95.1% from its 52-week high vs CPNG's 49.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.90x | 1.52x | 1.43x | 1.22x | 0.94x |
| 52-Week HighHighest price in past year | $3.33 | $34.08 | $278.56 | $2645.22 | $337.25 |
| 52-Week LowLowest price in past year | $2.15 | $14.92 | $197.28 | $1495.00 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +84.1% | +49.4% | +85.6% | +60.1% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 58.8 | 53.6 | 36.8 | 43.3 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 301K | 21.9M | 42.9M | 538K | 7.0M |
Analyst Outlook
JPM leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: HEPS as "Hold", CPNG as "Buy", AMZN as "Buy", MELI as "Buy", JPM as "Buy". Consensus price targets imply 55.8% upside for CPNG (target: $26) vs 5.9% for JPM (target: $340). JPM is the only dividend payer here at 1.86% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $26.20 | $307.77 | $2166.67 | $339.75 |
| # AnalystsCovering analysts | 2 | 16 | 94 | 33 | 61 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +1.9% |
| Dividend StreakConsecutive years of raises | — | — | — | 0 | 15 |
| Dividend / ShareAnnual DPS | — | — | — | — | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.8% | 0.0% | +0.0% | +3.9% |
JPM leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). AMZN leads in 1 (Profitability & Efficiency). 1 tied.
HEPS vs CPNG vs AMZN vs MELI vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HEPS or CPNG or AMZN or MELI or JPM a better buy right now?
For growth investors, D-Market Elektronik Hizmetler ve Ticaret A.
S. (HEPS) is the stronger pick with 61. 0% revenue growth year-over-year, versus 3. 3% for JPMorgan Chase & Co. (JPM). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Coupang, Inc. (CPNG) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HEPS or CPNG or AMZN or MELI or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 0x versus Coupang, Inc. at 152. 9x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Amazon. com, Inc. 's 0. 97x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — HEPS or CPNG or AMZN or MELI or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to -79. 2% for D-Market Elektronik Hizmetler ve Ticaret A. S. (HEPS). Over 10 years, the gap is even starker: MELI returned +1093% versus HEPS's -79. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HEPS or CPNG or AMZN or MELI or JPM?
By beta (market sensitivity over 5 years), D-Market Elektronik Hizmetler ve Ticaret A.
S. (HEPS) is the lower-risk stock at 0. 90β versus Coupang, Inc. 's 1. 52β — meaning CPNG is approximately 69% more volatile than HEPS relative to the S&P 500. On balance sheet safety, Amazon. com, Inc. (AMZN) carries a lower debt/equity ratio of 37% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — HEPS or CPNG or AMZN or MELI or JPM?
By revenue growth (latest reported year), D-Market Elektronik Hizmetler ve Ticaret A.
S. (HEPS) is pulling ahead at 61. 0% versus 3. 3% for JPMorgan Chase & Co. (JPM). On earnings-per-share growth, the picture is similar: Coupang, Inc. grew EPS 30. 5% year-over-year, compared to -286. 4% for D-Market Elektronik Hizmetler ve Ticaret A. S.. Over a 3-year CAGR, MELI leads at 38. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HEPS or CPNG or AMZN or MELI or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus -6. 7% for D-Market Elektronik Hizmetler ve Ticaret A. S. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -2. 4% for HEPS. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HEPS or CPNG or AMZN or MELI or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Amazon. com, Inc. 's 0. 97x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 4x forward P/E versus 40. 2x for MercadoLibre, Inc. — 25. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CPNG: 55. 8% to $26. 20.
08Which pays a better dividend — HEPS or CPNG or AMZN or MELI or JPM?
In this comparison, JPM (1.
9% yield) pays a dividend. HEPS, CPNG, AMZN, MELI do not pay a meaningful dividend and should not be held primarily for income.
09Is HEPS or CPNG or AMZN or MELI or JPM better for a retirement portfolio?
For long-horizon retirement investors, JPMorgan Chase & Co.
(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 9% yield, +465. 8% 10Y return). Coupang, Inc. (CPNG) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JPM: +465. 8%, CPNG: -65. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HEPS and CPNG and AMZN and MELI and JPM?
These companies operate in different sectors (HEPS (Consumer Cyclical) and CPNG (Consumer Cyclical) and AMZN (Consumer Cyclical) and MELI (Consumer Cyclical) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HEPS is a small-cap high-growth stock; CPNG is a mid-cap quality compounder stock; AMZN is a mega-cap quality compounder stock; MELI is a mid-cap high-growth stock; JPM is a large-cap deep-value stock. JPM pays a dividend while HEPS, CPNG, AMZN, MELI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.